Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Molson Coors €800 million notes offering
The notes are due 2032
Schlumberger Investment $500 million senior notes offering
The investment-grade notes are due 2034
Schlumberger Holdings $1 billion senior notes offering
The investment-grade notes are due 2027 and 2029
PayPal Holdings $1.25 billion notes offering
The investment-grade notes were issued in two tranches
Equinix $750 million bond offering
We advised Equinix on the investment-grade debt offering
Zebra Technologies $500 million senior notes offering
The high-yield notes are due 2032
Elevance Health $2.6 billion senior notes offering
The investment-grade notes are due 2029, 2034 and 2054
Morgan Stanley $2.75 billion senior notes offering
We advised Morgan Stanley on its 3(a)(2) notes offering
Merck €3.4 billion notes offering
The investment-grade notes offering consists of four tranches
KKR ¥91.4 billion senior notes offering
The investment-grade notes offering consists of five tranches